An Early Phase 1 interventional study of NGF and Isotonic saline in Hyperalgesia, Pain Response and Healthy Subjects, sponsored by Aalborg University. Completed at 1 site in Denmark. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-02-15.
Sponsored by Aalborg University · Early Phase 1, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Hyperalgesia with a site in Denmark — none open to participants now, none under way, none of them phase 3. Hyperalgesia · Denmark.
Among the 17 studies in Hyperalgesia with a site in Denmark, this one is the 9th largest by enrollment of the 15 interventional ones that give a count, is the only one that started in 2018, is one of 4 in phase 1, and was the 16th registered.
166 studies on the registry are indexed under Hyperalgesia; 13 are open to participants now.
Browse Hyperalgesia studies →None of the 17 studies in Hyperalgesia with a site in Denmark is open now. The open studies under Hyperalgesia, anywhere →
Of the 7 Hyperalgesia studies recruiting now, 4 set no upper age limit and 1 stops at 75 or younger; 2 take children under 18; 2 take healthy volunteers.
This study: 18 Years to 55 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 21 is below the median of 50 across 142 interventional studies indexed under Hyperalgesia.
Median enrollment 23 across the 15 interventional studies, 32 across the 2 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 17 has an industry lead sponsor. The 5 most frequent:
Aalborg University is the lead sponsor of 183 studies on the registry; 32 are open to participants now.
Aalborg University has 5 studies filed under Hyperalgesia — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 17 studies in Hyperalgesia with a site in Denmark, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to investigate pain evoked responses and facilitation of NGF-induced mechanical muscle hyperalgesia over time following an acute exercised-induced ischemic condition in a NGF-sensitized muscle.
Assessing evoked pain responses and muscle hyperalgesia following contractions during acute ischemia in a NGF-sensitized muscle may clarify whether an interaction between NGF sensitization and acidic stimulation exist.
It is hypothesized that acute ischemic exercise with the NGF-sensitized TA muscle, in contrast to ischemic exercise in a non-sensitized would: 1) potentiate pain-evoked responses, and 2) facilitate NGF-induced muscle hyperalgesia.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All participants will receive five injections with NGF (1ug/0.5ml) into the tibialis anterior muscle in their non-dominant leg After 4 weeks: All participants will receive five injections with isotonic saline (9%/0.5ml) into the tibialis anterior muscle in their non-dominant leg
Drug: NGF · Drug: Isotonic saline
All participants will receive five injections with isotonic saline (9%/0.5ml) into the tibialis anterior muscle in their non-dominant leg After 4 weeks: All participants will receive five injections with NGF (1ug/0.5ml) into the tibialis anterior muscle in their non-dominant leg
Drug: NGF · Drug: Isotonic saline
Intramuscular injection
Also known as: Beta-Nerve Growth Factor, Human
Intramuscular injection
Also known as: Control
Muscle sensitivity
Pressure pain thresholds (PPTs) are assessed over the non-dominant tibialis anterior muscle using a handhold pressure algometer.
Time frame: Change from baseline at 1 week
Ischemic-induced pain intensity
Subjects perform 45 dorsiflexions with their non-dominant leg while a cuff is mounted over the knee to occlude the blodflow from the muscle (ischemia) Subjects subsequently rate their perceived pain intensity verbally on a numeric rating scale (NRS)
Time frame: Assessed right after the dorsiflexions have been performed
Functional muscle pain
Subjects evaluate their muscle pain during movement using a Likert Scale for lower limp
Time frame: Change from baseline at 1 week
Muscle pain diary
Subjects evaluate their muscle pain during movement using a Likert Scale for lower limp and perceived pain intensity at rest on a numeric rating scale (NRS). The diary is filled out at home on days between sessions
Time frame: Change from baseline at 1 week
Plan to share: No
Ran from Mar 2018 to primary completion in May 2018, 2 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Nerve Growth Factor